Data / Form D filings / Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc.: Form D filings
Satsuma Pharmaceuticals, Inc., a pharmaceuticals company in South San Francisco, CA, filed 2 Form D notices with the SEC between 2016 and 2018. The latest, on February 12, 2018, reports $12.1 million sold of a $12.3 million offering to 4 investors.
Find out what Satsuma Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 Oyster Point Blvd., Suite 221, South San Francisco, CA, 94080
- Phone
- (415) 505-0809
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1692830
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2018 | Amendment | $12,288,750 | $12,134,401 | $154,349 | 4 | Dec 16, 2016 | sec.gov |
| Dec 29, 2016 | New notice | $12,288,750 | $6,000,000 | $6,288,750 | 3 | Dec 16, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Heath Lukatch | Director | |
| John Kollins | Executive Officer, Director | |
| Michael Riebe | Director | |
| Rajeev Shah | Director | |
| Tadayoshi Iwashima | Executive Officer | |
| Thomas King | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Feb 12, 2018 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Satsuma Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.